Extracellular vesicles from monocyte/platelet aggregates modulate human atherosclerotic plaque reactivity.


Journal

Journal of extracellular vesicles
ISSN: 2001-3078
Titre abrégé: J Extracell Vesicles
Pays: United States
ID NLM: 101610479

Informations de publication

Date de publication:
04 2021
Historique:
received: 08 06 2020
revised: 24 03 2021
accepted: 01 04 2021
entrez: 3 5 2021
pubmed: 4 5 2021
medline: 4 5 2021
Statut: ppublish

Résumé

Extracellular vesicles (EVs) are emerging as key players in different stages of atherosclerosis. Here we provide evidence that EVs released by mixed aggregates of monocytes and platelets in response to TNF-α display pro-inflammatory actions on endothelial cells and atherosclerotic plaques. Tempering platelet activation with Iloprost, Aspirin or a P2Y

Identifiants

pubmed: 33936566
doi: 10.1002/jev2.12084
pii: JEV212084
pmc: PMC8077084
doi:

Substances chimiques

Cytokines 0
Tumor Necrosis Factor-alpha 0
Aspirin R16CO5Y76E

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

12084

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Versus Arthritis
ID : 22235
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 101604/Z/13/Z
Pays : United Kingdom

Informations de copyright

© 2021 The Authors. Journal of Extracellular Vesicles published by Wiley Periodicals, LLC on behalf of the International Society for Extracellular Vesicles.

Références

BMC Genomics. 2012 Aug 01;13:357
pubmed: 22849433
Cell. 2019 Apr 4;177(2):428-445.e18
pubmed: 30951670
J Immunol. 2011 May 15;186(10):5543-7
pubmed: 21460209
Sci Rep. 2017 Aug 30;7(1):9954
pubmed: 28855621
Circ Heart Fail. 2013 Jan;6(1):127-35
pubmed: 23152489
Blood. 2011 Aug 25;118(8):2366-74
pubmed: 21700772
J Extracell Vesicles. 2021 Apr;10(6):12084
pubmed: 33936566
Front Cardiovasc Med. 2017 Nov 21;4:74
pubmed: 29209618
Atherosclerosis. 2011 Dec;219(2):734-6
pubmed: 21968316
J Immunol. 2017 Apr 1;198(7):2876-2885
pubmed: 28242648
Front Cardiovasc Med. 2018 Jan 22;5:2
pubmed: 29404342
Nat Med. 2003 Jan;9(1):61-7
pubmed: 12483207
J Proteomics. 2013 Apr 26;82:155-65
pubmed: 23429260
Thromb Haemost. 2008 Nov;100(5):878-85
pubmed: 18989533
JACC Basic Transl Sci. 2017 Dec 25;2(6):790-807
pubmed: 30062186
Arterioscler Thromb Vasc Biol. 2005 May;25(5):1065-70
pubmed: 15705928
J Intern Med. 2014 Feb;275(2):144-54
pubmed: 24118494
J Am Coll Cardiol. 1998 Feb;31(2):352-8
pubmed: 9462579
J Proteomics. 2012 Jun 6;75(10):2960-71
pubmed: 22197968
Pathophysiol Haemost Thromb. 2006;35(1-2):15-22
pubmed: 16855341
Arterioscler Thromb Vasc Biol. 2004 Jan;24(1):193-9
pubmed: 14615387
Eur Heart J. 2009 Dec;30(24):3048-54
pubmed: 19687162
Sci Rep. 2018 Jul 3;8(1):9987
pubmed: 29968812
J Am Coll Cardiol. 2008 Oct 14;52(16):1302-11
pubmed: 18929241
Front Pharmacol. 2019 Dec 17;10:1479
pubmed: 31920664
Sci Rep. 2014 Jun 10;4:5237
pubmed: 24913598
J Am Coll Cardiol. 1999 Nov 1;34(5):1420-6
pubmed: 10551687
J Thromb Haemost. 2018 Jul;16(7):1423-1436
pubmed: 29781099
Sci Rep. 2018 Jun 15;8(1):9209
pubmed: 29907817
Circulation. 2002 May 7;105(18):2166-71
pubmed: 11994250
Cardiovasc Res. 2020 Jan 1;116(1):202-210
pubmed: 30715163
Pulm Circ. 2013 Apr;3(2):329-40
pubmed: 24015332
Inflammation. 2019 Feb;42(1):290-305
pubmed: 30218321
Clin Pharmacol Ther. 2005 Nov;78(5):468-76
pubmed: 16321613
EMBO Mol Med. 2014 Jan;6(1):27-42
pubmed: 24357647
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
Ann N Y Acad Sci. 2010 Oct;1207:11-7
pubmed: 20955420
Eur Heart J. 2013 Oct;34(39):3028-34
pubmed: 24014390
J Am Coll Cardiol. 2007 Feb 20;49(7):772-7
pubmed: 17306706
FASEB J. 2016 Sep;30(9):3097-106
pubmed: 27226520
J Microsc. 2004 Jul;215(Pt 1):100-10
pubmed: 15230881
J Extracell Vesicles. 2014 Aug 06;3:
pubmed: 25147646
Lancet. 2012 Mar 31;379(9822):1214-24
pubmed: 22421340
Nat Methods. 2009 May;6(5):359-62
pubmed: 19377485
J Thromb Haemost. 2009 Jun;7(6):1019-28
pubmed: 19548909
Circ Cardiovasc Genet. 2009 Aug;2(4):379-88
pubmed: 20031610
Arterioscler Thromb Vasc Biol. 2014 Mar;34(3):571-80
pubmed: 24371083
Int J Cardiol. 2018 May 15;259:213-215
pubmed: 29579604
Transfusion. 2015 Mar;55(3):507-21
pubmed: 25332113
J Exp Med. 1996 Mar 1;183(3):1161-72
pubmed: 8642258
Cell Signal. 2020 Nov;75:109751
pubmed: 32860954
Circ Res. 2017 May 12;120(10):1649-1657
pubmed: 28495995
Mol Cell Proteomics. 2013 Aug;12(8):2205-19
pubmed: 23660474
J Biol Chem. 1999 Nov 19;274(47):33179-82
pubmed: 10559185
Science. 2016 Apr 8;352(6282):242-6
pubmed: 26989197
Platelets. 2012;23(5):368-75
pubmed: 22671289
PLoS One. 2011;6(10):e25595
pubmed: 22022418
J Cell Mol Med. 2012 Nov;16(11):2777-88
pubmed: 22697268
Arterioscler Thromb Vasc Biol. 1999 Oct;19(10):2364-7
pubmed: 10521365
J Am Coll Cardiol. 2001 Oct;38(4):1002-6
pubmed: 11583872

Auteurs

Silvia Oggero (S)

William Harvey Research Institute Bart's and the London School of Medicine Queen Mary University of London London UK.

Monica de Gaetano (M)

Diabetes Complications Research Centre Conway Institute, & School of Medicine University College Dublin Dublin Ireland.

Simone Marcone (S)

Trinity Translational Medicine Institute Trinity College Dublin Dublin Ireland.

Stephen Fitzsimons (S)

Diabetes Complications Research Centre Conway Institute, & School of Medicine University College Dublin Dublin Ireland.

Andreia L Pinto (AL)

Royal Brompton & Harefield NHS Foundation Trust London UK.

Dinara Ikramova (D)

School of Engineering and Materials Science Queen Mary University of London London UK.

Mary Barry (M)

Department of Vascular Surgery St. Vincent's University Hospital Dublin Ireland.

David Burke (D)

Department of Vascular Surgery St. Vincent's University Hospital Dublin Ireland.

Trinidad Montero-Melendez (T)

William Harvey Research Institute Bart's and the London School of Medicine Queen Mary University of London London UK.
Centre for inflammation and Therapeutic Innovation Queen Mary University of London London UK.

Dianne Cooper (D)

William Harvey Research Institute Bart's and the London School of Medicine Queen Mary University of London London UK.
Centre for inflammation and Therapeutic Innovation Queen Mary University of London London UK.

Thomas Burgoyne (T)

Royal Brompton & Harefield NHS Foundation Trust London UK.
Institute of Ophthalmology, Faculty of Brain Sciences University College London London UK.

Orina Belton (O)

Diabetes Complications Research Centre Conway Institute, & School of Medicine University College Dublin Dublin Ireland.

Lucy V Norling (LV)

William Harvey Research Institute Bart's and the London School of Medicine Queen Mary University of London London UK.
Centre for inflammation and Therapeutic Innovation Queen Mary University of London London UK.

Eoin P Brennan (EP)

Diabetes Complications Research Centre Conway Institute, & School of Medicine University College Dublin Dublin Ireland.

Catherine Godson (C)

Diabetes Complications Research Centre Conway Institute, & School of Medicine University College Dublin Dublin Ireland.

Mauro Perretti (M)

William Harvey Research Institute Bart's and the London School of Medicine Queen Mary University of London London UK.
Centre for inflammation and Therapeutic Innovation Queen Mary University of London London UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH